EGF and cancer: CIMAvax-EGF is a therapeutic cancer vaccine produced in the Center of Molecular Immunology, composed by human recombinant epidermal growth factor (EGF) conjugated to the carrier protein P64K from Neisseria meningitides and emulsified in Montanide ISA 51 (Seppic.http://www.seppic.com/index.html Puteaux Cedex, FRANCE).